Further evidence for our hypothesis was determined with the indication of the following cancer stem cell markers: GABRP, CTNNB1, and MYC, which are seen in breast, colon, and lung cancer stem cells [16,17,18]. This evidence concerns the gene GABRP and lung carcinoma.